Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
December 19, 2022	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000895345-22-000827.pdf 0000895345-22-000827.rtf View HTML
April 30, 2015	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-15-159089.pdf 0001193125-15-159089.rtf 0001193125-15-159089.xls View HTML
April 29, 2016	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-16-569332.pdf 0001193125-16-569332.rtf 0001193125-16-569332.xls View HTML
May 1, 2017	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-17-151808.pdf 0001193125-17-151808.rtf 0001193125-17-151808.xls View HTML
April 30, 2018	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-18-143093.pdf 0001193125-18-143093.rtf 0001193125-18-143093.xls View HTML
April 26, 2019	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-19-122326.pdf 0001193125-19-122326.rtf 0001193125-19-122326.xls View HTML
May 9, 2019	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-19-142313.pdf 0001193125-19-142313.rtf 0001193125-19-142313.xls View HTML
April 23, 2020	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-20-117193.pdf 0001193125-20-117193.rtf 0001193125-20-117193.xls View HTML
May 21, 2020	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-20-148687.pdf 0001193125-20-148687.rtf View HTML
April 22, 2021	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-21-126697.pdf 0001193125-21-126697.rtf 0001193125-21-126697.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax